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Recent studies of captive and wild-living apes in Africa
have uncovered evidence of numerous new Plasmodium
species, one of which was identified as the immediate
precursor of human Plasmodium falciparum. These find-
ings raise the question whether wild apes could be a
recurrent source of Plasmodium infections in humans.
This question is not new, but was the subject of intense
investigation by researchers in the first half of the last
century. Re-examination of their work in the context of
recent molecular findings provides a new framework
to understand the diversity of Plasmodium species
and to assess the risk of future cross-species transmis-
sions to humans in the context of proposed malaria
eradication programs.
Ape Plasmodium infections: a historical perspective
Plasmodium parasites are extraordinarily successful and
infectmany vertebrate hosts, ranging from reptiles to birds
to mammals. Our closest relatives, the African great apes,
are no exception. While working in Cameroon in 1917,
Eduard Reichenow observed three morphologically dis-
tinct Plasmodium parasites in the blood of chimpanzees
(Pan troglodytes) and gorillas (Gorilla gorilla) [1], a finding
soon confirmed by Saul Adler and Donald Blacklock in
Sierra Leone [2,3]. In the following decades, Plasmodium
parasites in gorillas and chimpanzees were studied at
several sites across west and central Africa [4–9]. The
consensus reached from this work was that there were
indeed three Plasmodium species infecting African great
apes, and that these were distinguishable based on their
life-cycle and morphology. One species bore a striking
resemblance to human P. falciparum, so much so that it
was initially assumed to be the same species; only later was
it accepted to be distinct, and named P. reichenowi [9]. A
second parasite in apes, P. rhodaini, closely resembled P.
malariae found in humans, whereas the third, P. schwetzi,
was more difficult to characterize and was referred to as P.
vivax-like or P. ovale-like by different investigators [10,11].
Recognizing that P. falciparum and P. reichenowi were
quite distinct from the other knownPlasmodium species, it
was suggested more than 50 years ago that the former
should be placed in a separate genus, Laverania [12].
Although this taxonomy was not widely adopted, the term
has recently been resurrected and is useful as a subgenus
designation [13].
Surprisingly, genetic material was obtained for only one
of these threePlasmodium species found in apes. In 1968, a
chimpanzee that had been imported into the USA was
found to be infected with P. reichenowi. The parasite
was isolated at the Centers for Disease Control (CDC)
and subsequently propagated for molecular and biological
analyses [14]. This P. reichenowi isolate has been used for
numerous comparative genetic studies [15–18], ranging
from single-gene to whole-genome analyses, for example,
to identify genes in P. falciparum that are under differen-
tial selection pressures [19]. A full-length genome sequence
is now nearing completion (M. Berriman, personal com-
munication). Although P. schwetzi was also isolated by the
CDC [11,20], no aliquots of this isolate apparently remain,
and no DNA was ever recovered from this specimen (J.W.
Barnwell, personal communication). P. rhodainiwas never
genetically characterized.
A molecular revolution: ape parasites revisited
This view of the three species of Plasmodium in apes from
west and central Africa (P. reichenowi, P. schwetzi and P.
rhodaini), which mirror the three human Plasmodium
species (P. falciparum, P. ovale and P. malariae) found
in the same regions, has been completely revised in the
past two years. The first suspicion that the old descriptors
might not be sufficient came from the identification of
parasites morphologically resembling P. falciparum in
two pet chimpanzees from Gabon [21]. When the complete
mitochondrial genome of one of these parasites was se-
quenced, it became clear that it was related to, but quite
divergent from, P. falciparum and the CDC isolate of
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P. reichenowi. This led to the proposal of a new species, P.
gaboni. Four additional studies rapidly followed that also
reported sequences from P. falciparum-like parasites in
African apes [13,22–24]. All of these pointed to the exis-
tence of additional species within the Laverania subgenus
[13,21–24], but their precise number and true host associa-
tions were unclear. For example, various chimpanzee-de-
rived lineages were all placed in one species [22], or split
into four species [13,24]. In addition, only relatively few
samples were analyzed, most of which were derived from
sanctuary apes that could have become infected in captivi-
ty. Finally, some of the new sequences were clearly poly-
merase chain reaction (PCR)-induced hybrids which
formed lineages intermediate between clades [23].
These uncertainties have since been resolved by a large-
scale molecular epidemiological study [25] that used non-
invasive methods (Box 1) to examine nearly 3,000 fecal
samples from wild-living apes at multiple sites across
Africa (Figure 1). PCR primers were designed to amplify
Plasmodium mitochondrial, apicoplast and nuclear
sequences from ape fecal DNA. Importantly, a single-ge-
nome amplification (SGA) approach was used to preclude
in vitro artifacts that frequently occur when conventional
PCR is used to amplify mixtures of genetically diverse
templates (as is the case in many Plasmodium infections)
[25]. The study revealed that wild apes harbored parasites
that fell into six discretemajor clades within the Laverania
subgenus (Figure 2). The host specificity of these clades
was intriguing: sequences from three of these lineages
were found only in chimpanzee samples, whereas
sequences from the other three clades were found only
in samples from western gorillas (G. gorilla), even when
both of these host species were sampled at the same
geographical location. In contrast, Plasmodium sequences
were not detected in eastern gorillas (G. beringei) or bono-
bos (P. paniscus) despite several hundred samples being
tested [25]. The samples taken from eastern gorillas were
collected at sites no more than 500–700 m above sea level.
Hence, the absence ofLaverania parasites was not simply a
function of high altitude.
A minimum of six ape Laverania species
Naming these various Laverania clades as different Plas-
modium species on the basis of genetic information alone is
likely to be controversial, but seems necessary at this time.
The endangered status of African apes will make it difficult
to obtain infected blood to derive Plasmodium isolates.
Moreover, the high frequency of mixed-species infections
(see below) will confound meaningful correlations of para-
site morphology with genetic information from the same
sample. Thus, it is unclear if and when the morphological
and biological data traditionally used for the taxonomic
description of new Plasmodium species will become avail-
able. However, there is a pressing need for a standardized
nomenclature to provide a common framework for future
research because there is confusion surrounding recently
proposed species names. We believe that a strong case can
be made that the six clades of ape Plasmodium sequences
reflect distinct parasite species. Nevertheless, we recog-
nize that the proposal described below will remain tenta-
tive until a full taxonomic evaluation has been completed.
Several lines of evidence indicate that the six lineages
within Laverania each represent a distinct species. First,
the various mtDNA clades are at least as divergent from
each other as are P. falciparum and P. reichenowi [25],
which in turn are much more divergent than the two
recently proposed species within P. ovale [26]. Second,
as noted above, the clades exhibit remarkably strict host
specificity, indicating isolation at least between the para-
sites infecting chimpanzees and gorillas. Third, both of
these aspects of the mtDNA phylogeny are recapitulated
by sequences from the two other parasite genomes, i.e. the
clpC gene from apicoplast DNA and the ldh gene from the
nuclear genome, despite the fact that fewer clpC and ldh
sequences were analyzed [25]. The apicoplast genome
appears to be uniparentally inherited in the same fashion
as mtDNA [27–29]. However, biparentally inherited nucle-
ar genes can assort independently of the organelle gen-
omes and so the ldh data in particular indicate that the
division into six clades is not an artifact of the mode of
mtDNA inheritance. Statistical support for the clades in
the clpC and ldh trees is not as strong as it is for the clades
in the mtDNA tree, but this probably reflects a reduced
phylogenetic signal due to lower diversity in these
sequences. Finally, the clades are not merely geographi-
cally defined. For example, sequences from each of the
three chimpanzee parasite clades include samples from
all four Pan troglodytes subspecies from sample sites as far
apart as Cote d’Ivoire and western Uganda [25,30]. In light
Box 1. Approaches to studying Plasmodium infection in
apes
All African apes are highly endangered, thus precluding invasive
studies of wild populations. Given this, options to study ape
Plasmodium infections are limited. One strategy is to partner with
ape sanctuaries and analyze specimens collected for diagnostic
purposes as part of routine health measures. The advantage of this
approach is access to blood samples, which may yield parasite
isolates as well as Plasmodium sequences. The disadvantage is that
sanctuary apes live in close proximity to humans and may thus be
exposed to, and possibly infected by, human parasites. The other
strategy is to screen ape fecal samples collected from the forest
floor (Figure I) or, in the case of habituated communities, tissue
samples from apes that are found dead, for Plasmodium infections
[22,30]. The advantage of this approach is that much larger numbers
of apes can be studied, and that all individuals are sampled within
their natural habitat. The disadvantage is that parasite loads may be
much lower than in blood samples, and that morphological
characterization of parasites is not possible.[()TD$FIG]
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Figure I. Non-invasive testing of ape Plasmodium infections. An ape fecal
sample is collected at a remote forest site by an experienced tracker and
preserved for shipment and storage in RNAlater (Ambion).
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of the evidence shown above, it is clearly not appropriate to
use P. reichenowi as an ‘umbrella term’ covering multiple
lineages of ape Plasmodium parasites [22].
Initially, we termed the six Laverania clades C1–C3 and
G1–G3, depending on whether they comprised chimpanzee
or gorilla samples, respectively [25]. Clade C1 includes the
CDC isolate of P. reichenowi, and should retain that his-
torical name. Sequences falling within clades C2 and C3
have previously been termed P. gaboni [21], and P. bill-
collinsi [13], respectively. However, sequences correspond-
ing to another recently proposed species, P. billbrayi [13],
fall within the C2 clade and do not seem to be sufficiently
distinct from P. gaboni to warrant a separate species
designation at this time. The three species from the gorilla
have not yet been named. For G2 and G3, we propose P.
adleri and P. blacklocki, respectively, in honor of Saul
Adler (1895–1966) and Donald Blacklock (1879–1953),
two of the pioneers of malaria research in apes. The third
clade of gorilla parasites (G1) includes human P. falci-
parum. This clade appears to have originated in gorillas,
with human P. falciparum parasites having arisen from a
single cross-species transmission (see below) such that
they may now be effectively isolated from their gorilla
precursors. If so, then the human and gorilla parasites
within the G1 clade also represent distinct species. In this
case, we propose the name P. praefalciparum for the
parasites infecting gorillas to emphasize their role as
the precursor of human P. falciparum. This nomenclature
is summarized in Figure 2.
The origin of P. falciparum
Sequences from human strains of P. falciparum are closely
related to sequences of parasites from western gorillas
[24,25], but other closely related sequences have also been
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Figure 1. Geographic distribution, species association and prevalence of ape Plasmodium infections in sub-Saharan Africa. Field sites where wild-living chimpanzees and
bonobos (a), or gorillas (b) were sampled are shown. Sites where ape Plasmodium infections were detected are highlighted in yellow, with the estimated prevalence
indicated [25,30]. The upper panel depicts the ranges of the four subspecies of the common chimpanzee (Pan troglodytes verus, gray; P. t. ellioti,magenta; P. t. troglodytes,
red; and P. t. schweinfurthii, blue) and of the bonobo (P. paniscus, orange). The lower panel depicts the ranges of western (Gorilla gorilla, green) and eastern (G. beringei,
brown) gorillas (map courtesy of Lilian Pintea, The Jane Goodall Institute, Arlington, Virginia, USA.).
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reported from chimpanzee [23] and bonobo samples [13].
Various authors have argued that each of these three ape
species were the primordial hosts of this clade. In addition,
it has most recently been suggested that all of these ape
infections with P. falciparum-like parasites are a very
recent phenomenon ‘occurring only as a result of forest
destruction that has brought human and ape populations
into greater proximity, thus facilitating the transmission of
human P. falciparum to gorillas’ [31]. However, existing
lines of evidence clearly implicate gorillas as the original
source of these parasites.
The P. falciparum-like sequences form the clade previ-
ously termed G1 [25]. G1 sequences were obtained from
four bonobos who had been housed at a sanctuary on the
outskirts of a major city (Kinshasa, Democratic Republic of
the Congo), and from two chimpanzees who were kept as
pets before sampling [13,23]. However, no G1 sequences
were found in >1,800 samples from wild chimpanzees and
no Laverania sequences of any kind were detected in
samples from wild bonobos [25]. This strongly suggests
that the six sanctuary apes acquired human-derived Plas-
modium infections while in captivity. This hypothesis
seems to have been confirmed by the observations that
these G1 sequences from bonobos and chimpanzees fall
within the radiation of sequences from human strains [25],
and that the bonobo strains carried drug resistance muta-
tions found in human P. falciparum [13].
In striking contrast, the gorilla-derived G1 sequences
came from numerous wild-living individuals sampled at 11
sites across the range of the western gorilla in Cameroon,
the Central African Republic, and the Republic of Congo
[25]. These G1 sequences from gorillas exhibit high levels
of mtDNA diversity, similar to those seen in other ape
Laverania species, such as P. reichenowi in chimpanzees.
Conversely, human-derived G1 sequences (i.e. human P.
falciparum) are much less diverse, and in phylogenetic
trees form a single well-supported clade within the radia-
tion of gorilla-derived G1 sequences [25]. These observa-
tions would be difficult to explain if humans were the
original hosts of the G1 clade, and especially if, as sug-
gested [31], transmission to gorillas had occurred only very
recently. Thus, all the available evidence indicates that
western gorillas served as the source of human P. falci-
parum, and not the other way around. Also, there is not a
single confirmed case of human P. falciparum infection in
wild-living gorillas. Although one study reported two go-
rilla-derived G1 sequences that were identical to human P.
falciparum [24], the amplified fragment was too short to
differentiate human from gorilla G1 parasites [25].
Host species specificity
The apparent host specificity of the Laverania species
could be due to incompatibility at the parasite–host and/
or the vector–host interface. It has been suggested that P.
reichenowi and P. falciparum are specific to their respec-
tive chimpanzee and human hosts because of incompati-
bility at the erythrocyte entry stage. Invasion of human
erythrocytes by P. falciparum merozoites relies heavily
(although not exclusively) upon the interaction between
the parasite ligand EBA-175 and its erythrocyte sialogly-
coprotein receptor, glycophorin A (GPA) [32]. Sialic acid
residues are present in one of two forms, the precursor
form, N-aceytlneuraminic acid (Neu5Ac), or its modified
product, N-glycolylneuraminic acid (Neu5Gc); the former
is converted to the latter by an enzyme encoded by the
CMAH gene [33,34]. Ape sialoglycoproteins contain pre-
dominantly Neu5Gc but the human CMAH gene contains
an inactivating insertion, so human sialoglycoproteins
contain only Neu5Ac residues [35]. Experimental studies
have suggested that this Neu5Ac/Neu5Gc difference ren-
ders themajorP. falciparum ligandEBA-175unable to bind
to chimpanzee GPA, whereas the P. reichenowi homolog of
EBA-175 cannot bind to human GPA [36]. This sialic acid
hypothesis cannot explain the host preferences of the vari-
ousapeLaverania speciesbecause chimpanzeesandgorillas
express similar repertoires of sialic acids [35]. However,
adaptation to the human sialic acid repertoire could have
played a part in the isolation of human P. falciparum from
its gorilla-infecting precursor, just as it was originally pro-
posed to have had a role in the speciation of P. falciparum
from P. reichenowi [36,37]. With our new understanding
of the diversity of Laverania parasites, assessing the recep-
tor-binding specificity of all parasites will be an important
test to validate the sialic acid hypothesis.
Natural history of ape Plasmodium infections
Non-invasive studies of Plasmodium infections have also
provided the first estimates of Laverania prevalence rates
in wild apes [25,30]. The results were striking: Laverania
parasites were not only widely distributed but also highly
prevalent in chimpanzees and western gorillas (Figure 1).
Moreover, the reported prevalence rates represent mini-
mum estimates because the extent to which infected apes
shed PlasmodiumDNA into their feces is not known.What
do these prevalence rates tell us about the pathogenesis of
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Figure 2. Phylogeny of ape-derived Plasmodium mitochondrial sequences:
identifying six clades within the Laverania subgenus. A summary representation
of an analysis of nearly 700 SGA-derived ape Plasmodium cytb sequences is
shown (modified from Supplementary Figure 3 in [25]). Clades are summarized as
triangles; the height of each triangle reflects the number of sequences, whereas
the depth denotes the maximum divergence within each clade. Green and
magenta colors highlight Laverania parasites from gorillas (G1–G3) and
chimpanzees (C1–C3), respectively (non-Laverania parasites are shown in
yellow). Each clade reflects a distinct species; pre-existing or proposed names
for these species are shown on the right. The black triangle indicates human P.
falciparum sequences, which form a monophyletic clade within the G1 radiation of
gorilla parasites.
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Laverania parasites in chimpanzees and gorillas? Given
the extremely high infection rates in some communities, it
is probably safe to assume that severe malaria is not a
frequent outcome of ape Laverania infections. No patho-
logical consequences were noted in early studies of natu-
rally infected apes [1], although the small numbers of cases
examined and the frequent occurrence of co-infecting
pathogens precluded definitive conclusions. Interestingly,
Laverania infection rates in apes appear to be similar to P.
falciparum prevalence rates in humans in hyperendemic
transmission zones. In these regions, adults are largely
immune to the clinical manifestations of malaria, but
frequently maintain high-level P. falciparum infections
in their blood [38]. It therefore seems probable that apes
develop clinical immunity to Laverania parasites in much
the sameway that humans do. Thus, ifLaverania parasites
cause mortality in apes, it would be expected to occur in
infants because in humans most P. falciparum mortality
occurs in children under the age of 5 years. The other
potential complication of ape Laverania infections may
be in pregnant females because P. falciparum can cause
placental complications in infected women. Screening
Laverania parasites for genes associated with pregnancy
complications, such as the cytoadherence ligand var2CSA
[39], may help to answer this question.
Non-Laverania infections in wild apes
Recent studies have not only revealed a much greater
diversity of P. falciparum-related ape parasites, but also
uncovered non-Laverania species in these same popula-
tions. Screening samples of feces or blood from apes with
consensus primers generally leads to the amplification of
Laverania sequences, suggesting that these parasites are
present at high titers, just as P. falciparum is usually the
predominant parasite in human mixed-species infections
[40]. However, parasites related to P. ovale, P. vivax and P.
malariae have now also been found in samples from apes
[30,41,42]. The presence of P. vivax-related parasites in
African apes is of particular relevance because the origins
of human P. vivax are controversial. Several studies have
suggested an origin in South-East Asia because the closest
known relatives of P. vivax infect primates in this region
[43,44]. However, this seems difficult to reconcile with the
near fixation of the Duffy negative allele in human popula-
tions in central Africa. The Duffy antigen is a chemokine
receptor required by P. vivaxmerozoites to enter red blood
cells. The very high frequency of the negative genotype is
suggestive of a prolonged exposure toP. vivax in this region
[45]. The new data raise the possibility that humans in
west central Africa may have been exposed to P. vivax-like
parasites from apes over an extended period of time.
The discovery of P. ovale- and P. vivax-related parasites
in apes also resolves some of the confusion surrounding P.
schwetzi, which has been variously described as P. vivax-
like or P. ovale-like. It seems likely that, in at least some
cases, researchers were viewing different species in differ-
ent ape samples but calling them by the same name. This is
not surprising given that the distinction between P. ovale
and P. vivax in humans was disputed for many years [46]
and it was not until the 1940s that the two were widely and
consistently recognized as separate species [47]. Similarly,
it is likely that ape parasites previously termed ‘P. reich-
enowi’ comprised representatives of different Laverania
species. Obviously, a complete understanding of the diver-
sity of these parasites (together with an appropriate no-
menclature) will be critical to assess the risk of future
zoonoses.
Are humans susceptible to infection with ape
Plasmodium parasites?
It is now apparent that Plasmodium parasites are widely
distributed in wild-living great apes, with multiple Laver-
ania and non-Laverania species present, often at the same
location and in the same individual, with prevalence
approaching 100% at some sites. This opens up the possi-
bility of comparative studies of ape and human parasites
that could provide new and important insights into the
pathobiology of human malaria. However, one important
question raised by the new findings is the same as that
posed by Eduard Reichenow when he first observed these
parasites: do they serve as a source for human infection?
Much is already known about the ability of ape Plasmo-
dium parasites to infect humans. In the decades following
their discovery, a series of transmission experiments in-
volving apes and humans were carried out. While unthink-
able today, these studies nevertheless generated very
valuable information. In the case of P. rhodaini, the data
were unequivocal, with numerous studies showing that
this parasite transmitted readily between apes and
humans in both directions [8,48–50]. Given the ease of
these transfers, Rhodain even argued that P. rhodaini and
P. malariae were the same species [48]. The data for P.
vivax and P. ovale are also fairly clear (although experi-
ments were carried out with ‘P. schwetzi’ which, as noted
above, could have represented either one or both of these
parasites). ‘P. schwetzi’ was transmitted from apes to
humans on more than one occasion [11,51–53]. In at least
one of these cases, ‘P. schwetzi’ may have been a P. vivax-
related parasite because transmissions were successful if
the recipients were Caucasians but not if they were Afri-
cans, perhaps due to the Duffy negativity of the latter [53].
In other cases, the resulting blood infections in humans
were distinctly P. ovale-like [11]. It is therefore possible
that transmission experiments were undertaken with both
parasites and that both P. vivax and P. ovale can be
transmitted from apes to humans.
The potential of Laverania parasites to cross between
different hosts is less clear. As depicted in Figure 2, current
evidence indicates that pandemic human P. falciparum
arose after a single human-to-gorilla transmission event.
The question is whether such jumps have occurred more
than once. This has certainly been observed for other ape-
derived zoonotic infections, including simian immunodefi-
ciency viruses from chimpanzees and gorillas, which gave
rise to human immunodeficiency virus (HIV)-1. These ape
viruses have jumped to humans on at least four indepen-
dent occasions, with the current AIDS pandemic being the
result of only one such transmission event [54]. The fact
that several attempts to infect humans with ‘P. reichenowi’
failed [2] does not argue against ape-to-human Laverania
transmissions. All recorded cross-species infection experi-
ments involved chimpanzee parasites, but precisely which
Review Trends in Parasitology May 2011, Vol. 27, No. 5
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chimpanzee Laverania species were tested is not known.
These experiments therefore show that some chimpanzee
Laverania parasites may not transfer readily to humans,
but this may not be true for all of them. Most importantly,
there is no record of an attempted transfer of ‘P. reichenowi’
from gorillas to humans.
What is the likelihood of ape-to-human parasite
transmission?
Given that human P. falciparum appears to have originat-
ed in gorillas, and that P. malariae-, P. ovale- and P. vivax-
like ape parasites have been experimentally transmitted to
humans on several occasions, the question arises: ‘‘to what
extent are humans in west and central Africa exposed to
infection with ape parasites?’’ In this context, vector sus-
ceptibility and host feeding preferences are important
variables. Many successful ape–human transmission
experiments were carried out with Plasmodium-infected
blood, but some were carried out using infected mosquitoes
[53]. Thus, ape Plasmodium parasites can spread to
humans via the bites of at least some vector species. Under
field conditions, cross-species transmission would require
an Anopheles mosquito to bite an infected ape and to then
take a human blood meal. Studies have addressed the
extent to which various Anopheles species are susceptible
to ape Plasmodium parasites. Importantly, attempts to
inoculate ‘P. reichenowi’ into A. gambiae (the major human
vector) failed [10,14,55]. However, it is currently not known
which species transmit Plasmodium between wild apes.
Hence, the ability of these mosquitoes to act as bridging
vectors (which would have amajor impact on the likelihood
of ape-to-human transmission) remains to be determined.
It will also be important to determine how many indi-
viduals live or work in close proximity to wild apes such
that they would be exposed to Anopheles mosquitoes that
have recently fed on apes. Dispersal of Anopheles in re-
lease–recapture experiments is 200–500 m [56] (although
in some studies distances of over 1000 m have also been
reported [57]). Humans living or working within 500 m of
infected apes (including hunters, who routinely spend
several days and nights in hunting camps in forests) are
at greatest risk of exposure to ape Plasmodium-infected
mosquitoes. Nevertheless, exposure is not limited to hun-
ters because Plasmodium-positive fecal samples from apes
have been collected within 500 m of human habitations
(Figure 3). Depending on the dispersal characteristics of
the respective vectors, exposure at much greater distances
may also be possible [58].
The question thus arises why there is currently no
evidence for zoonotic transmissions, particularly involving
ape Plasmodium species where experimental infection has
been documented. One answer is that most cases of malar-
ia are not diagnosed but are treated presumptively based
on symptoms. Moreover, ape Plasmodium parasites have
not been exposed to drug-selection pressure. Hence, they
would probably be sensitive to all anti-malarial agents, and
would thus be eliminated by presumptive treatment even
with chloroquine or sulfadoxine-pyrimethamine. Even in
cases with positive blood smears, ape Plasmodium para-
sites would probably go unrecognized given their morpho-
logical similarity to human parasites. All original studies
describing ‘P. reichenowi’ remarked on how similar this ape
parasite was to human P. falciparum. It therefore seems
likely thatmany (if not all) of the variousLaverania species
would be misidentified as P. falciparum by diagnostic
microscopy. Similarly, ape-derived parasites related to
P. malariae, P. vivax and P. ovale would probably look like
their respective human counterparts and thus be diag-
nosed as such. Human infection with themacaque parasite
P. knowlesi is an illuminating case in point. This zoonosis
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Figure 3. Proximity of Plasmodium-infected wild-living apes to human habitation. The location of chimpanzee fecal samples collected near a village (black triangle) in
southeastern Cameroon (inset) is shown. Plasmodium-positive and -negative samples are depicted by red and yellow triangles, respectively. Samples are numbered with
capital letters indicating the field site, with their location determined using global positioning system (GPS) coordinates. Plasmodium-positive samples were found within
315 m of human habitation and in close proximity to a nearby road (brown line). The map was generated using Google Maps Pro (the scale bar represents 1 km); white
areas indicate cloud cover.
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(which comprises several thousand cases every year) was
initially misdiagnosed as P. malariae based on parasite
morphology [59]. Even now, the diagnosis requires careful
differential morphological examination combined with
Plasmodium species-specific PCR [60]. Such approaches
have not been used in regions of ape/human co-habitation
in Africa.
The way forward: an action plan
Numerous individuals in west and central Africa live and
work in areas where they may encounter mosquitoes that
have fed on Plasmodium-infected apes. Experiments car-
ried out in the first half of the last century established that
some ape Plasmodium parasites can be transmitted to
humans. For others (including the gorilla parasite that
gave rise to human P. falciparum), experimental data are
lacking. Given the magnitude of the ape Plasmodium
reservoir and the fact that a gorilla Plasmodium has
crossed the species barrier to humans at least once, the
question arises whether additional cross-species transfers
of ape parasites have occurred or are occurring.
What needs to be done to address this question defini-
tively? The distribution, prevalence and host associations
of Laverania species have been determined [25]. Hence, it
is important to screen wild apes for P. vivax-, P. ovale- and
P. malariae-related parasites because it is for these species
that the experimental evidence of cross-transmission is the
strongest. Additional sequence information is also needed
to provide a clearer picture of their phylogenetic relation-
ships to the respective human infections, which will be
informative as to whether ape-to-human and/or human-to-
ape transfers have occurred. In the case of P. vivax-related
parasites, this is of particular interest because human P.
vivax is supposedly absent from west and central Africa
[61]. In the case of P. ovale, which was recently proposed to
comprise two separate species [26,62], this may help to
illuminate the origins of these parasites. It is also likely,
given the diversity of parasites identified so far, that
additional ape Plasmodium species will be identified in
African apes.
Secondly, humans living near wild-ape communities
will need to be tested for zoonotic infections using molecu-
lar approaches capable of differentiating ape parasites.
Mitochondrial polymorphisms unique to ape Laverania
parasites may prove useful for this purpose [25]. Human
P. falciparum infections in hyperendemic transmission
areas frequently comprise mixtures of multiple genotypes.
Detecting ape Plasmodium sequences in these mixtures
may not be possible using standard PCR approaches,
particularly if ape Plasmodium species are less fit than
extant human Plasmodium parasites and therefore might
be present at very low levels. ‘Next-generation’ sequencing
such as 454 pyrosequencing, which generates tens of thou-
sands of sequence reads from a single sample, could reveal
such low-abundance infections. Characterizing the ‘micro-
biome’ of within-hostPlasmodium diversity will also reveal
new insights into the complexity and ecology of human
mixed-parasite infections [63].
Finally, the mosquito species that transmit Plasmodi-
um parasites among African apes will need to be identified
in order to establish their potential to act as bridging
vectors. Candidates include A. moucheti and A. nili, two
known humanmalaria vectors found in and around forests
across the area of west and central Africa that overlaps the
ranges of the great apes [64]. However, current under-
standing of forest-dwelling Anopheles species is too limited
to draw definitive conclusions. An active program that
entails capturing Anopheles in close proximity of ape nest-
ing sites and analyzing them for Plasmodium infections
using molecular tools is clearly needed.
The approaches outlined above, together with biological
studies of erythrocyte invasion and cytoadherence, prom-
ise to provide a comprehensive dataset to assess the risk of
ape Plasmodium zoonoses. This information is of consid-
erable public health importance not because such trans-
missions would be expected to contribute significantly to
current malaria morbidity and mortality but because they
would give an indication of the potential of ape malaria
parasites to colonize humans in the future. This question of
the risk and scale of potential zoonoses is particularly
timely because plans for eradication of P. falciparum are
beginning to be formalized [65]. If these programs are
successful in reducing transmission within local human
populations, they could open-up new niches for previously
limited cross-species transfers to expand and potentially
re-seed humans with new infections. Eduard Reichenow’s
question, first posed nearly a century ago, will finally be
addressed, but with the benefit of a considerably advanced
toolkit.
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